References
- Brenner S. 1974. Caenorhabditis elegans. Genetics. 77(1):71–94.
- Fahmy NM, Al-Sayed E, El-Shazly M, Nasser Singab A. 2019. Alkaloids of genus Erythrina: an updated review. Nat Prod Res. 21:1–22.
- Huang L, Huang L, Luo Y, Pu Z, Kong X, Fu X, Xing H, Wei S, Chen W, Tang H. 2017. Oxoisoaporphine alkaloid derivative 8-1 reduces Aβ1-42 secretion and toxicity in human cell and Caenorhabditis elegans models of Alzheimer’s disease. Neurochem Int. 108:1–12.
- Negreiros TSNN, Gardner D, Hallwass F, Leite AJM, de Almeida CG, Silva LN, de Araújo Roque A, de Bitencourt FG, Barbosa EG, Tasca T, et al. 2016. Activity of pyrrolizidine alkaloids against biofilm formation and Trichomonas vaginalis. Biomed Pharmacother. 83:323–329.
- Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. 2013. The global prevalence of dementia: a systematic review and metanalysis. Alzheimers Dement. 9(1):63–75.
- Rambo DF, Biegelmeyer R, Toson NSB, Dresch RR, Moreno PRH, Henriques AT. 2019. The genus Erythrina L.: a review on its alkaloids, preclinical, and clinical studies. Phytother Res. 33(5):1258–1276.
- Xin L, Yamujala R, Wang Y, Wang H, Wu WH, Lawton MA, Long C, Di R. 2013. Acetylcholinesterase-inhibiting alkaloids from Lycoris radiata delay paralysis of amyloid beta-expressing transgenic C. elegans CL4176. PLoS One. 8(5):e63874.